Molecular Templates
company
About
Molecular Templates develops novel therapeutic compounds for cancer.
- 251 - 500
Details
- Last Funding Type
- Post-IPO Equity
- Last Funding Money Raised
- $60M
- Industries
- Biotechnology,Health Care,Therapeutics
- Founded date
- Jan 1, 2000
- Number Of Employee
- 251 - 500
- Operating Status
- Active
Molecular Templates is a biopharmaceutical company with a novel protein platform for the development of new therapeutics against cancer. The company has a lead compound for melanoma that is expected to enter into clinical trials in the next two years and is developing additional compounds against a variety of other cancers.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$60.15M
Molecular Templates has raised a total of
$60.15M
in funding over 2 rounds. Their latest funding was raised on
Aug 16, 2017 from a Post-IPO Equity round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 16, 2017 | Post-IPO Equity | $60M | 1 | — | — | Detail |
| Jan 1, 2010 | Grant | $153.93K | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Molecular Templates is funded by 2 investors.
Takeda
and National Institutes of Health
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Takeda
|
— | Post-IPO Equity |
National Institutes of Health
|
— | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
